T-cell Receptor–Engineered T Cells Show Efficacy in HPV+ Carcinomas

Article navigation

Research Watch| May 01 2021

T-cell Receptor–Engineered T Cells Show Efficacy in HPV⁺ Carcinomas

Online ISSN: 2159-8290

Print ISSN: 2159-8274

2021

American Association for Cancer Research.

Cancer Discov (2021) 11 (5): OF15.

A T-cell receptor T-cell therapy showed early promise in human papillomavirus (HPV)–linked cancers.

2021

American Association for Cancer Research.

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.